

Vijoice costs over $31,000/month. Here's how to save with copay cards, patient assistance programs, and other financial help options in 2026.
Vijoice (Alpelisib) 50 mg is the only FDA-approved medication for PIK3CA-Related Overgrowth Spectrum (PROS), and for many patients and families, it's an essential part of managing this rare condition. But at a cash price of approximately $31,754 for a 28-day supply, affording Vijoice without help isn't realistic for most people.
The good news is that there are real programs designed to bring that cost down significantly—in many cases, to $0 per month. Here's a comprehensive look at every option available in 2026.
Let's start with the numbers:
All strengths and formulations are priced similarly per 28-day cycle. Without insurance or financial assistance, this adds up to approximately $381,000 per year.
Because there is no generic version of Vijoice available, brand pricing is the only option. For background on the medication itself, see our article on what is Vijoice: uses, dosage, and what you need to know.
The most impactful savings program for commercially insured patients is the Novartis Oncology Universal Co-Pay Program.
How it works:
How to enroll:
Eligibility:
This program can reduce your out-of-pocket cost from thousands of dollars per month to zero. If you have commercial insurance, this should be your first call.
If you're uninsured, underinsured, or can't afford your out-of-pocket costs even with insurance, the following programs may provide Vijoice at no cost:
The manufacturer's own patient assistance program provides free Vijoice to eligible patients.
This is the primary safety net for patients who cannot afford Vijoice and don't have adequate insurance coverage.
PAN is an independent nonprofit that offers copay assistance for patients with specific medical conditions.
PAN funds can open and close based on donations, so check availability periodically.
These are databases that aggregate patient assistance programs and can help you find additional resources:
Some pharmacy discount platforms list Vijoice, though savings may be limited compared to manufacturer programs:
For a specialty medication like Vijoice, discount cards are less effective than manufacturer copay programs and patient assistance. Focus your energy on the Novartis programs first.
The Novartis Co-Pay Program does not apply to patients on Medicare, Medicaid, or other government insurance. However:
At over $31,000 per month, Vijoice 50 Mg 28 Day is one of the most expensive prescriptions a patient can face. But with the right financial assistance—especially the Novartis copay program and patient assistance foundation—most patients can access this critical medication at significantly reduced cost, and many pay nothing at all.
The key is to start the enrollment process early. Don't wait until you receive a bill or face a gap in coverage. Contact Novartis patient support at 1-877-577-7756 as soon as you have a prescription, and get financial assistance set up alongside your prior authorization and specialty pharmacy enrollment.
For more on accessing Vijoice, check out our guides on how to find Vijoice in stock near you and the Vijoice shortage update for 2026. You can also search for availability at Medfinder.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.